Company’s 36-month beta value is 0.39.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for YS is 17.94M, and currently, short sellers hold a 0.65% ratio of that floaft. The average trading volume of YS on March 28, 2024 was 202.51K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
YS) stock’s latest price update
The stock of YS Biopharma Co Ltd (NASDAQ: YS) has increased by 12.70 when compared to last closing price of 0.63.Despite this, the company has seen a gain of 12.70% in its stock price over the last five trading days. InvestorPlace reported 2023-12-19 that While the topic of top penny stocks to buy may arouse controversy similar to apocryphal literature with spiritual implications. That might sound hyperbolic but generally, financial advisors shy away from the sector because of the extreme risks involved.
YS’s Market Performance
YS Biopharma Co Ltd (YS) has seen a 12.70% rise in stock performance for the week, with a 77.54% gain in the past month and a 54.31% surge in the past quarter. The volatility ratio for the week is 14.05%, and the volatility levels for the past 30 days are at 15.94% for YS. The simple moving average for the past 20 days is 16.95% for YS’s stock, with a -11.49% simple moving average for the past 200 days.
YS Trading at 42.06% from the 50-Day Moving Average
After a stumble in the market that brought YS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -85.77% of loss for the given period.
Volatility was left at 15.94%, however, over the last 30 days, the volatility rate increased by 14.05%, as shares surge +84.42% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +40.07% upper at present.
During the last 5 trading sessions, YS rose by +12.70%, which changed the moving average for the period of 200-days by -47.01% in comparison to the 20-day moving average, which settled at $0.6234. In addition, YS Biopharma Co Ltd saw 38.94% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for YS
Current profitability levels for the company are sitting at:
- -0.4 for the present operating margin
- 0.8 for the gross margin
The net margin for YS Biopharma Co Ltd stands at -0.36. The total capital return value is set at -0.2.
The debt to equity ratio resting at 0.99. The interest coverage ratio of the stock is -8.41.
Currently, EBITDA for the company is -76.82 million with net debt to EBITDA at -1.95. When we switch over and look at the enterprise to sales, we see a ratio of 2.7. The receivables turnover for the company is 1.09for trailing twelve months and the total asset turnover is 0.29. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.41.
Conclusion
In a nutshell, YS Biopharma Co Ltd (YS) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
